Pharmacokinetics and Toxicity of Continuous Infusion Amphotericin B in Cancer Patients
- 1 April 1989
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 78 (4), 307-310
- https://doi.org/10.1002/jps.2600780409
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Effects of amphotericin B on combination chemotherapy of metastatic sarcomasCancer, 1984
- Measurement of amphotericin b in serum or plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- Phase II study of 1,3-Bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC #409962) with amphotericin B in bronchogenic carcinomaCancer, 1980
- Amphotericin B Pharmacokinetics in HumansAntimicrobial Agents and Chemotherapy, 1978
- Amphotericin B plus 1,3-BIS (2-chloroethyl)-1-nitrosourea (BCNU-NSC NO. 409962) in advanced cancer.Phase I and preliminary phase II resultsCancer, 1976
- Chemotherapy of Systemic MycosesNew England Journal of Medicine, 1974
- Stability of Amphotericin B in Infusion BottlesAntimicrobial Agents and Chemotherapy, 1973
- A Pharmacologic Guide to the Clinical Use of Amphotericin BThe Journal of Infectious Diseases, 1969